معرفی
Ryan Mulholland is a Researcher in Health Economics and Health Technology Assessment at the University of Glasgow, affiliated with the School of Health and Wellbeing. He joined HEHTA in 2022 after completing a medical degree at the University of Edinburgh (2018) and an MSc in Precision Medicine and Pharmacological Innovation at the University of Glasgow (2020, Distinction).
- Medical Doctor (MBChB, University of Edinburgh, 2018)
- MSc Precision Medicine & Pharmacological Innovation (University of Glasgow, 2020)
His research focuses on real-world evidence in HTA, particularly in oncology and cardiovascular disease, including economic evaluation alongside clinical trials. He also investigates linked health data analysis and the economics of precision medicine.
His recent publications address healthcare costs and inequalities in oral anti-coagulant prescribing for atrial fibrillation patients, emphasizing pharmacoeconomics and outcomes research.
Ryan contributes to teaching on MSc HTA courses such as 'Real-world data in healthcare decision making' and 'Health economics for HTA,' and supervises MSc dissertations. He actively participates in community engagement initiatives and diversity efforts through the School's Athena Swan LGBTQ+ working group.
